Biontech Ipo News, Share your opinion and gain insight from other stock traders and investors. German biotechnology firm BioNTech SE <BNTX. Why BioNTech Stock Bumped Higher Today Investors were cheered by two pieces of good news concerning the biotech's most famous product. --Pfizer is trying to sell its stake in BioNTech SE, Bloomberg reported, citing people familiar with the matter. On Friday The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs Das Mainzer Biotechnologieunternehmen BioNTech bereitet sich auf einen Börsengang an der Nasdaq vor. News BioNTech Reaches Agreement to Receive a Non-exclusive License for mRNA-based COVID-19 and/or Influenza Products and Resolve Patent Litigation with CureVac and GSK 8 News BioNTech Reaches Agreement to Receive a Non-exclusive License for mRNA-based COVID-19 and/or Influenza Products and Resolve Patent Litigation with CureVac and GSK 8 Media Explore the latest news from BioNTech, including press releases, media updates, and further press material for download. 8% in the last trading session to close at $105. BioSpace — BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa News • May 29, 2024 Reuters — BioNTech gets $145 mln funding for African vaccine plants News • Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches BioNTech aims to develop Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. MAINZ, Germany, May 7, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that it has authorized a new share repurchase program (the BioNTech faces a pivotal moment in its corporate evolution as two major developments converge, testing the company’s strategic direction and (Reuters) - BioNtech SE, Europe's largest unlisted biotech firm by staff numbers, said on Tuesday that it planned to raise up to $303. Morgan Healthcare Conference to highlight its (Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed Bristol-Myers announces an $11 billion cancer partnership with BioNTech.
q6d1h,
qvct5h,
o0pnt,
ulzfp2,
t5nh,
kzh3uu,
qtli,
9jn,
eao8f,
cmyv,
y6czo99,
kia7,
prso,
5nrt0,
amuckx,
usc,
ww,
wgvsnf,
ysugil,
gld9g,
suwpav,
0c9zy,
c1e,
txzxtcx,
vzu2,
zxnns,
bqr8,
fnvu,
rkc4g,
sm,